Head of research group
Prof. Dr. Dr. Kirsten R. Müller-Vahl
Excellence at a glance:
- Since 2020: President of the European Society for the Study of Tourette syndrome (ESSTS)
- Since 2019: 1st Chair of the International Association Cannabis as Medicine (IACM)
- Since 2019: 1st Chairwoman of the Working Group Cannabis as Medicine (ACM)
- 2019: Co-editor of the standard work on "Cannabis as medicine": Müller-Vahl KR, Grotenhermen F (eds). Cannabis as medicine, Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2020. ISBN: 978-3-95466-509-9
- From 2017-2019: Several times active as an individual expert in hearings in the German Bundestag on the "Cannabis Act"
- 2017: IACM Award: "IACM Award for Clinical Research for her special achievements regarding the re-introduction of cannabis and cannabinoids as medicine".
- Since 2017: Associate Editor for "Cannabis and Cannabinoid Research", since 2018 Editorial board member for "Medical Cannabis and Cannabinoids"
- Since 2016: Member of the Expert Committee for Narcotics at the Federal Opium Agency of the Federal Institute for Drugs and Medical Devices (BfArM))
- 2014: Editor of the standard work on Tourette syndrome: Müller-Vahl K. Tourette syndrome and other tic disorders. 2nd, updated and expanded edition, Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2014. ISBN: 978-3-95466-099-5
- 2012: Science Award of the Tourette Society Germany TGD e.V.
- Expert at the Federal Highway Research Institute (BAST)
- Principal investigator in numerous studies funded by the DFG, BMBF, EU, NIMH and industry
- Specialist in psychiatry and neurology